193 related articles for article (PubMed ID: 16447098)
1. TNF-receptor-associated periodic syndrome (TRAPS): an autosomal dominant multisystem disorder.
Rezaei N
Clin Rheumatol; 2006 Nov; 25(6):773-7. PubMed ID: 16447098
[TBL] [Abstract][Full Text] [Related]
2. The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers.
Aksentijevich I; Galon J; Soares M; Mansfield E; Hull K; Oh HH; Goldbach-Mansky R; Dean J; Athreya B; Reginato AJ; Henrickson M; Pons-Estel B; O'Shea JJ; Kastner DL
Am J Hum Genet; 2001 Aug; 69(2):301-14. PubMed ID: 11443543
[TBL] [Abstract][Full Text] [Related]
3. The tumour necrosis factor receptor-associated periodic syndrome: current concepts.
Stojanov S; McDermott MF
Expert Rev Mol Med; 2005 Oct; 7(22):1-18. PubMed ID: 16216134
[TBL] [Abstract][Full Text] [Related]
4. Familial clustering of recurrent pericarditis may disclose tumour necrosis factor receptor-associated periodic syndrome.
Cantarini L; Lucherini OM; Baldari CT; Laghi Pasini F; Galeazzi M
Clin Exp Rheumatol; 2010; 28(3):405-7. PubMed ID: 20497634
[TBL] [Abstract][Full Text] [Related]
5. The novel S59P mutation in the TNFRSF1A gene identified in an adult onset TNF receptor associated periodic syndrome (TRAPS) constitutively activates NF-κB pathway.
Greco E; Aita A; Galozzi P; Gava A; Sfriso P; Negm OH; Tighe P; Caso F; Navaglia F; Dazzo E; De Bortoli M; Rampazzo A; Obici L; Donadei S; Merlini G; Plebani M; Todd I; Basso D; Punzi L
Arthritis Res Ther; 2015 Apr; 17(1):93. PubMed ID: 25888769
[TBL] [Abstract][Full Text] [Related]
6. Severe TNF receptor-associated periodic syndrome due to 2 TNFRSF1A mutations including a new F60V substitution.
Haas SL; Lohse P; Schmitt WH; Hildenbrand R; Karaorman M; Singer MV; Böcker U
Gastroenterology; 2006 Jan; 130(1):172-8. PubMed ID: 16401480
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes.
Aganna E; Hammond L; Hawkins PN; Aldea A; McKee SA; van Amstel HK; Mischung C; Kusuhara K; Saulsbury FT; Lachmann HJ; Bybee A; McDermott EM; La Regina M; Arostegui JI; Campistol JM; Worthington S; High KP; Molloy MG; Baker N; Bidwell JL; Castañer JL; Whiteford ML; Janssens-Korpola PL; Manna R; Powell RJ; Woo P; Solis P; Minden K; Frenkel J; Yagüe J; Mirakian RM; Hitman GA; McDermott MF
Arthritis Rheum; 2003 Sep; 48(9):2632-44. PubMed ID: 13130484
[TBL] [Abstract][Full Text] [Related]
8. Identification of a novel mevalonate kinase gene mutation in combination with the common MVK V377I substitution and the low-penetrance TNFRSF1A R92Q mutation.
Hoffmann F; Lohse P; Stojanov S; Shin YS; Renner ED; Kéry A; Zellerer S; Belohradsky BH
Eur J Hum Genet; 2005 Apr; 13(4):510-2. PubMed ID: 15657603
[TBL] [Abstract][Full Text] [Related]
9. A novel mutation (T61I) in the gene encoding tumour necrosis factor receptor superfamily 1A (TNFRSF1A) in a Japanese patient with tumour necrosis factor receptor-associated periodic syndrome (TRAPS) associated with systemic lupus erythematosus.
Ida H; Kawasaki E; Miyashita T; Tanaka F; Kamachi M; Izumi Y; Huang M; Tamai M; Origuchi T; Kawakami A; Migita K; Motomura M; Yoshimura T; Eguchi K
Rheumatology (Oxford); 2004 Oct; 43(10):1292-9. PubMed ID: 15280569
[TBL] [Abstract][Full Text] [Related]
10. "Periodic fever" without fever: two cases of non-febrile TRAPS with mutations in the TNFRSF1A gene presenting with episodes of inflammation or monosymptomatic amyloidosis.
Kallinich T; Haffner D; Rudolph B; Schindler R; Canaan-Kühl S; Keitzer R; Burmester GR; Roesen-Wolff A; Roesler J
Ann Rheum Dis; 2006 Jul; 65(7):958-60. PubMed ID: 16308343
[TBL] [Abstract][Full Text] [Related]
11. The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder.
Hull KM; Drewe E; Aksentijevich I; Singh HK; Wong K; McDermott EM; Dean J; Powell RJ; Kastner DL
Medicine (Baltimore); 2002 Sep; 81(5):349-68. PubMed ID: 12352631
[TBL] [Abstract][Full Text] [Related]
12. Candidate genes in patients with autoinflammatory syndrome resembling tumor necrosis factor receptor-associated periodic syndrome without mutations in the TNFRSF1A gene.
Borghini S; Fiore M; Di Duca M; Caroli F; Finetti M; Santamaria G; Ferlito F; Bua F; Picco P; Obici L; Martini A; Gattorno M; Ceccherini I
J Rheumatol; 2011 Jul; 38(7):1378-84. PubMed ID: 21459945
[TBL] [Abstract][Full Text] [Related]
13. Multiple sclerosis and the TNFRSF1A R92Q mutation: clinical characteristics of 21 cases.
Kümpfel T; Hoffmann LA; Pellkofer H; Pöllmann W; Feneberg W; Hohlfeld R; Lohse P
Neurology; 2008 Nov; 71(22):1812-20. PubMed ID: 19029521
[TBL] [Abstract][Full Text] [Related]
14. Modeling of tumor necrosis factor receptor superfamily 1A mutants associated with tumor necrosis factor receptor-associated periodic syndrome indicates misfolding consistent with abnormal function.
Rebelo SL; Bainbridge SE; Amel-Kashipaz MR; Radford PM; Powell RJ; Todd I; Tighe PJ
Arthritis Rheum; 2006 Aug; 54(8):2674-87. PubMed ID: 16871532
[TBL] [Abstract][Full Text] [Related]
15. Mutant forms of tumour necrosis factor receptor I that occur in TNF-receptor-associated periodic syndrome retain signalling functions but show abnormal behaviour.
Todd I; Radford PM; Draper-Morgan KA; McIntosh R; Bainbridge S; Dickinson P; Jamhawi L; Sansaridis M; Huggins ML; Tighe PJ; Powell RJ
Immunology; 2004 Sep; 113(1):65-79. PubMed ID: 15312137
[TBL] [Abstract][Full Text] [Related]
16. TNF receptor-associated periodic syndrome (TRAPS): description of a novel TNFRSF1A mutation and response to etanercept.
Jesus AA; Oliveira JB; Aksentijevich I; Fujihira E; Carneiro-Sampaio MM; Duarte AJ; Silva CA
Eur J Pediatr; 2008 Dec; 167(12):1421-5. PubMed ID: 18408954
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome.
Cantarini L; Lucherini OM; Cimaz R; Baldari CT; Bellisai F; Rossi Paccani S; Laghi Pasini F; Capecchi PL; Sebastiani GD; Galeazzi M
Int J Immunopathol Pharmacol; 2009; 22(4):1051-8. PubMed ID: 20074469
[TBL] [Abstract][Full Text] [Related]
18. Systemic cytokine levels and the effects of etanercept in TNF receptor-associated periodic syndrome (TRAPS) involving a C33Y mutation in TNFRSF1A.
Nowlan ML; Drewe E; Bulsara H; Esposito N; Robins RA; Tighe PJ; Powell RJ; Todd I
Rheumatology (Oxford); 2006 Jan; 45(1):31-7. PubMed ID: 16287931
[TBL] [Abstract][Full Text] [Related]
19. Novel markers of inflammation identified in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) by transcriptomic analysis of effects of TRAPS-associated tumor necrosis factor receptor type I mutations in an endothelial cell line.
Rebelo SL; Amel-Kashipaz MR; Radford PM; Bainbridge SE; Fiets R; Fang J; McDermott EM; Powell RJ; Todd I; Tighe PJ
Arthritis Rheum; 2009 Jan; 60(1):269-80. PubMed ID: 19116900
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of the MVK and TNFRSF1A genes in patients with a clinical presentation typical of the hyperimmunoglobulinemia D with periodic fever syndrome: a low-penetrance TNFRSF1A variant in a heterozygous MVK carrier possibly influences the phenotype of hyperimmunoglobulinemia D with periodic fever syndrome or vice versa.
Stojanov S; Lohse P; Lohse P; Hoffmann F; Renner ED; Zellerer S; Kéry A; Shin YS; Haas D; Hoffmann GF; Belohradsky BH
Arthritis Rheum; 2004 Jun; 50(6):1951-8. PubMed ID: 15188372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
